-
Revenue
$-297.56M
Net Income
-
Gross Margin
-
Op. Margin
$-123.22M
Free Cash Flow
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
|---|---|---|---|---|
| Total Revenue | - | $1.64M | - | - |
| Revenue Growth % | nan% | nan% | nan% | - |
| Cost of Revenue | - | $1.45M | - | - |
| Gross Profit | - | $195.00K | - | - |
| Gross Margin % | nan% | 11.9% | nan% | - |
| Research & Development | $15.88M | $15.88M | $6.34M | - |
| Operating Income | $-59.50M | $-59.50M | $-4.08M | - |
| Operating Margin % | nan% | -3621.6% | nan% | - |
| Interest Expense | - | $17.00K | - | - |
| Interest Income | $5.45M | $5.45M | $292.00K | - |
| Other Income/Expense | $-239.18M | $-239.18M | $11.98M | - |
| Income Before Tax | - | $-298.68M | $-16.39M | - |
| Income Tax Expense | - | $-160.00K | - | - |
| Net Income | $-297.56M | $-297.56M | $7.90M | - |
| Net Margin % | nan% | -18110.7% | nan% | - |
| Basic EPS | nan | -3.31 | -0.40 | - |
| Diluted EPS | nan | -3.31 | -0.40 | - |
| Basic Shares Outstanding | 2.4M | 98.0M | 59.5M | - |
| Diluted Shares Outstanding | 2.4M | 98.0M | 59.5M | - |
| Breakdown | FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
|---|---|---|---|
| Cash & Cash Equivalents | $359.93M | $16.76M | $275.67K |
| Accounts Receivable | $3.76M | - | - |
| Inventory | $18.54M | - | - |
| Other Current Assets | $3.15M | $378.00K | - |
| Total Current Assets | $385.38M | $60.50K | $499.66K |
| Property Plant & Equipment | $85.41M | $26.53M | - |
| Goodwill | $134.85M | - | - |
| Intangible Assets | $68.61M | - | - |
| Long-term Investments | - | $24.08M | $258.97M |
| Other Non-current Assets | $176.00K | $52.00K | - |
| Total Assets | $695.00M | $24.14M | $259.47M |
| Accounts Payable | $11.07M | $1.82M | - |
| Accrued Liabilities | $14.07M | $3.07M | $234.99K |
| Deferred Revenue | $10.50M | - | - |
| Other Current Liabilities | - | $13.00K | - |
| Total Current Liabilities | $37.91M | $3.94M | $309.99K |
| Deferred Tax Liabilities | $16.71M | - | - |
| Total Liabilities | $191.81M | $17.09M | $13.41M |
| Common Stock | $15.00K | $6.00K | - |
| Retained Earnings | $-387.36M | $-17.03M | $-12.91M |
| Total Stockholders Equity | $494.29M | $-17.03M | $-12.91M |
| Total Liabilities & Equity | $695.00M | $24.14M | $259.47M |
| Breakdown | TTM (Dec 31, 2025) |
FY 2025 (Dec 31, 2025) |
FY 2024 (Dec 31, 2024) |
FY 2023 (Dec 31, 2023) |
|---|---|---|---|---|
| Net Income | $-297.56M | $-297.56M | $7.90M | - |
| Depreciation & Amortization | - | $763.00K | $235.00K | - |
| Stock-based Compensation | $11.32M | $8.76M | $1.74M | - |
| Change in Receivables | - | $599.00K | - | - |
| Change in Inventory | - | $3.21M | - | - |
| Change in Payables | $-9.88M | $-5.49M | $1.09M | - |
| Operating Cash Flow | $-77.55M | $-48.98M | $-1.40M | - |
| Capital Expenditure | $45.67M | $37.36M | $3.11M | - |
| Acquisitions | - | $102.21M | - | - |
| Investing Cash Flow | $-148.91M | $-139.57M | $246.92M | - |
| Stock Repurchased | - | - | $246.92M | - |
| Financing Cash Flow | $681.25M | $531.72M | $-245.79M | - |
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing
Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Research & Development | $4.45M | $1.16M | $8.72M | $4.94M |
| Operating Income | $-15.86M | $-1.96M | $-33.38M | $-9.67M |
| Interest Income | $1.31M | $23.00K | $2.26M | $177.00K |
| Other Income/Expense | $-141.13M | $-49.00K | $-214.64M | $169.00K |
| Net Income | $-156.68M | $-1.87M | $-247.35M | $-8.94M |
| Basic EPS | -1.64 | -0.03 | -2.83 | -0.15 |
| Diluted EPS | -1.64 | -0.03 | -2.83 | -0.15 |
| Basic Shares Outstanding | $102.59M | $59.50M | $95.61M | $59.43M |
| Diluted Shares Outstanding | $102.59M | $59.50M | $95.61M | $59.43M |
Condensed Consolidated Balance Sheets
| Description | Sep 30, 2025 | Dec 31, 2024 |
|---|---|---|
| Cash & Cash Equivalents | $257.61M | $16.76M |
| Other Current Assets | $1.27M | $378.00K |
| Total Current Assets | $258.88M | $22.27M |
| Other Non-current Assets | $33.00K | $52.00K |
| Total Assets | $323.32M | $69.07M |
| Accounts Payable | $1.83M | $1.82M |
| Accrued Liabilities | $13.42M | $3.07M |
| Other Current Liabilities | - | $13.00K |
| Total Current Liabilities | $15.68M | $6.92M |
| Total Liabilities | $368.63M | $15.12M |
| Common Stock | $11.00K | $6.00K |
| Retained Earnings | $-337.18M | $-72.87M |
| Total Stockholders Equity | $-58.58M | $34.02M |
| Total Liabilities & Equity | $323.32M | $69.07M |
Condensed Consolidated Statements of Cash Flows
| Description | Sep 30, 2025 | Sep 30, 2025 | ||
|---|---|---|---|---|
| Current | Prior Year | Current YTD | Prior Year YTD | |
| Net Income | $-156.68M | $-1.87M | $-247.35M | $-8.94M |
| Stock-based Compensation | - | - | $4.29M | $192.00K |
| Change in Payables | - | - | $-3.40M | $944.00K |
| Operating Cash Flow | - | - | $-21.09M | $-9.49M |
| Capital Expenditure | - | - | $13.40M | $2.26M |
| Investing Cash Flow | - | - | $-13.40M | $-2.47M |
| Financing Cash Flow | - | - | $275.33M | $21.75M |
All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.
Annual data represents full fiscal year results. FY = Fiscal Year ending.